Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Prednisone
1.2.3 Methotrexate
1.2.4 Tocilizumab
1.2.5 Aspirin
1.3 Market by Application
1.3.1 Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Corticosteroids
1.3.3 Immunosuppressive Agents
1.3.4 Anticoagulants
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Giant Cell Arteritis Therapeutic Market Perspective (2018-2029)
2.2 Global Giant Cell Arteritis Therapeutic Growth Trends by Region
2.2.1 Giant Cell Arteritis Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Giant Cell Arteritis Therapeutic Historic Market Size by Region (2018-2024)
2.2.3 Giant Cell Arteritis Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Giant Cell Arteritis Therapeutic Market Dynamics
2.3.1 Giant Cell Arteritis Therapeutic Industry Trends
2.3.2 Giant Cell Arteritis Therapeutic Market Drivers
2.3.3 Giant Cell Arteritis Therapeutic Market Challenges
2.3.4 Giant Cell Arteritis Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Giant Cell Arteritis Therapeutic by Players
3.1.1 Global Giant Cell Arteritis Therapeutic Revenue by Players (2018-2024)
3.1.2 Global Giant Cell Arteritis Therapeutic Revenue Market Share by Players (2018-2024)
3.2 Global Giant Cell Arteritis Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Giant Cell Arteritis Therapeutic, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Giant Cell Arteritis Therapeutic Market Concentration Ratio
3.4.1 Global Giant Cell Arteritis Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Giant Cell Arteritis Therapeutic Revenue in 2022
3.5 Global Key Players of Giant Cell Arteritis Therapeutic Head office and Area Served
3.6 Global Key Players of Giant Cell Arteritis Therapeutic, Product and Application
3.7 Global Key Players of Giant Cell Arteritis Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Giant Cell Arteritis Therapeutic Breakdown Data by Type
4.1 Global Giant Cell Arteritis Therapeutic Historic Market Size by Type (2018-2024)
4.2 Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Type (2024-2029)
5 Giant Cell Arteritis Therapeutic Breakdown Data by Application
5.1 Global Giant Cell Arteritis Therapeutic Historic Market Size by Application (2018-2024)
5.2 Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Giant Cell Arteritis Therapeutic Market Size (2018-2029)
6.2 North America Giant Cell Arteritis Therapeutic Market Size by Type
6.2.1 North America Giant Cell Arteritis Therapeutic Market Size by Type (2018-2024)
6.2.2 North America Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029)
6.2.3 North America Giant Cell Arteritis Therapeutic Market Share by Type (2018-2029)
6.3 North America Giant Cell Arteritis Therapeutic Market Size by Application
6.3.1 North America Giant Cell Arteritis Therapeutic Market Size by Application (2018-2024)
6.3.2 North America Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029)
6.3.3 North America Giant Cell Arteritis Therapeutic Market Share by Application (2018-2029)
6.4 North America Giant Cell Arteritis Therapeutic Market Size by Country
6.4.1 North America Giant Cell Arteritis Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Giant Cell Arteritis Therapeutic Market Size by Country (2018-2024)
6.4.3 North America Giant Cell Arteritis Therapeutic Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Giant Cell Arteritis Therapeutic Market Size (2018-2029)
7.2 Europe Giant Cell Arteritis Therapeutic Market Size by Type
7.2.1 Europe Giant Cell Arteritis Therapeutic Market Size by Type (2018-2024)
7.2.2 Europe Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029)
7.2.3 Europe Giant Cell Arteritis Therapeutic Market Share by Type (2018-2029)
7.3 Europe Giant Cell Arteritis Therapeutic Market Size by Application
7.3.1 Europe Giant Cell Arteritis Therapeutic Market Size by Application (2018-2024)
7.3.2 Europe Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029)
7.3.3 Europe Giant Cell Arteritis Therapeutic Market Share by Application (2018-2029)
7.4 Europe Giant Cell Arteritis Therapeutic Market Size by Country
7.4.1 Europe Giant Cell Arteritis Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Giant Cell Arteritis Therapeutic Market Size by Country (2018-2024)
7.4.3 Europe Giant Cell Arteritis Therapeutic Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Giant Cell Arteritis Therapeutic Market Size (2018-2029)
8.2 China Giant Cell Arteritis Therapeutic Market Size by Type
8.2.1 China Giant Cell Arteritis Therapeutic Market Size by Type (2018-2024)
8.2.2 China Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029)
8.2.3 China Giant Cell Arteritis Therapeutic Market Share by Type (2018-2029)
8.3 China Giant Cell Arteritis Therapeutic Market Size by Application
8.3.1 China Giant Cell Arteritis Therapeutic Market Size by Application (2018-2024)
8.3.2 China Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029)
8.3.3 China Giant Cell Arteritis Therapeutic Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Giant Cell Arteritis Therapeutic Market Size (2018-2029)
9.2 Asia Giant Cell Arteritis Therapeutic Market Size by Type
9.2.1 Asia Giant Cell Arteritis Therapeutic Market Size by Type (2018-2024)
9.2.2 Asia Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029)
9.2.3 Asia Giant Cell Arteritis Therapeutic Market Share by Type (2018-2029)
9.3 Asia Giant Cell Arteritis Therapeutic Market Size by Application
9.3.1 Asia Giant Cell Arteritis Therapeutic Market Size by Application (2018-2024)
9.3.2 Asia Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029)
9.3.3 Asia Giant Cell Arteritis Therapeutic Market Share by Application (2018-2029)
9.4 Asia Giant Cell Arteritis Therapeutic Market Size by Region
9.4.1 Asia Giant Cell Arteritis Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Giant Cell Arteritis Therapeutic Market Size by Region (2018-2024)
9.4.3 Asia Giant Cell Arteritis Therapeutic Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Giant Cell Arteritis Therapeutic Introduction
11.1.4 Sanofi Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.1.5 Sanofi Recent Developments
11.2 Kiniksa Pharmaceuticals, Ltd.
11.2.1 Kiniksa Pharmaceuticals, Ltd. Company Details
11.2.2 Kiniksa Pharmaceuticals, Ltd. Business Overview
11.2.3 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Introduction
11.2.4 Kiniksa Pharmaceuticals, Ltd. Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.2.5 Kiniksa Pharmaceuticals, Ltd. Recent Developments
11.3 Regeneron
11.3.1 Regeneron Company Details
11.3.2 Regeneron Business Overview
11.3.3 Regeneron Giant Cell Arteritis Therapeutic Introduction
11.3.4 Regeneron Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.3.5 Regeneron Recent Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Introduction
11.4.4 GlaxoSmithKline plc Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.4.5 GlaxoSmithKline plc Recent Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Giant Cell Arteritis Therapeutic Introduction
11.6.4 Novartis AG Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.6.5 Novartis AG Recent Developments
11.7 AbbVie, Inc.
11.7.1 AbbVie, Inc. Company Details
11.7.2 AbbVie, Inc. Business Overview
11.7.3 AbbVie, Inc. Giant Cell Arteritis Therapeutic Introduction
11.7.4 AbbVie, Inc. Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.7.5 AbbVie, Inc. Recent Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Details
11.8.2 Bristol-Myers Squibb Company Business Overview
11.8.3 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Introduction
11.8.4 Bristol-Myers Squibb Company Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.8.5 Bristol-Myers Squibb Company Recent Developments
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Giant Cell Arteritis Therapeutic Introduction
11.9.4 Abbott Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.9.5 Abbott Recent Developments
11.10 Johnson & Johnson Services, Inc.
11.10.1 Johnson & Johnson Services, Inc. Company Details
11.10.2 Johnson & Johnson Services, Inc. Business Overview
11.10.3 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Introduction
11.10.4 Johnson & Johnson Services, Inc. Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.10.5 Johnson & Johnson Services, Inc. Recent Developments
11.11 Johns Hopkins Hospital
11.11.1 Johns Hopkins Hospital Company Details
11.11.2 Johns Hopkins Hospital Business Overview
11.11.3 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Introduction
11.11.4 Johns Hopkins Hospital Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.11.5 Johns Hopkins Hospital Recent Developments
11.12 Fortis Healthcare
11.12.1 Fortis Healthcare Company Details
11.12.2 Fortis Healthcare Business Overview
11.12.3 Fortis Healthcare Giant Cell Arteritis Therapeutic Introduction
11.12.4 Fortis Healthcare Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.12.5 Fortis Healthcare Recent Developments
11.13 American College of Rheumatology
11.13.1 American College of Rheumatology Company Details
11.13.2 American College of Rheumatology Business Overview
11.13.3 American College of Rheumatology Giant Cell Arteritis Therapeutic Introduction
11.13.4 American College of Rheumatology Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.13.5 American College of Rheumatology Recent Developments
11.14 Duke University Health System
11.14.1 Duke University Health System Company Details
11.14.2 Duke University Health System Business Overview
11.14.3 Duke University Health System Giant Cell Arteritis Therapeutic Introduction
11.14.4 Duke University Health System Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.14.5 Duke University Health System Recent Developments
11.15 Lahey Clinic Foundation
11.15.1 Lahey Clinic Foundation Company Details
11.15.2 Lahey Clinic Foundation Business Overview
11.15.3 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Introduction
11.15.4 Lahey Clinic Foundation Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024)
11.15.5 Lahey Clinic Foundation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Prednisone
Table 3. Key Players of Methotrexate
Table 4. Key Players of Tocilizumab
Table 5. Key Players of Aspirin
Table 6. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Giant Cell Arteritis Therapeutic Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Giant Cell Arteritis Therapeutic Market Share by Region (2018-2024)
Table 10. Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Giant Cell Arteritis Therapeutic Market Share by Region (2024-2029)
Table 12. Giant Cell Arteritis Therapeutic Market Trends
Table 13. Giant Cell Arteritis Therapeutic Market Drivers
Table 14. Giant Cell Arteritis Therapeutic Market Challenges
Table 15. Giant Cell Arteritis Therapeutic Market Restraints
Table 16. Global Giant Cell Arteritis Therapeutic Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Giant Cell Arteritis Therapeutic Revenue Share by Players (2018-2024)
Table 18. Global Top Giant Cell Arteritis Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Therapeutic as of 2022)
Table 19. Global Giant Cell Arteritis Therapeutic Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Giant Cell Arteritis Therapeutic Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Giant Cell Arteritis Therapeutic, Headquarters and Area Served
Table 22. Global Key Players of Giant Cell Arteritis Therapeutic, Product and Application
Table 23. Global Key Players of Giant Cell Arteritis Therapeutic, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Giant Cell Arteritis Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Type (2018-2024)
Table 27. Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Type (2024-2029)
Table 29. Global Giant Cell Arteritis Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Giant Cell Arteritis Therapeutic Revenue Share by Application (2018-2024)
Table 31. Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Giant Cell Arteritis Therapeutic Revenue Share by Application (2024-2029)
Table 33. North America Giant Cell Arteritis Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Giant Cell Arteritis Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Giant Cell Arteritis Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Giant Cell Arteritis Therapeutic Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Giant Cell Arteritis Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Giant Cell Arteritis Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Giant Cell Arteritis Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Giant Cell Arteritis Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Giant Cell Arteritis Therapeutic Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Giant Cell Arteritis Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Giant Cell Arteritis Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Giant Cell Arteritis Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Giant Cell Arteritis Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Giant Cell Arteritis Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Giant Cell Arteritis Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Giant Cell Arteritis Therapeutic Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Giant Cell Arteritis Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 65. Sanofi Company Details
Table 66. Sanofi Business Overview
Table 67. Sanofi Giant Cell Arteritis Therapeutic Product
Table 68. Sanofi Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 69. Sanofi Recent Developments
Table 70. Kiniksa Pharmaceuticals, Ltd. Company Details
Table 71. Kiniksa Pharmaceuticals, Ltd. Business Overview
Table 72. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product
Table 73. Kiniksa Pharmaceuticals, Ltd. Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 74. Kiniksa Pharmaceuticals, Ltd. Recent Developments
Table 75. Regeneron Company Details
Table 76. Regeneron Business Overview
Table 77. Regeneron Giant Cell Arteritis Therapeutic Product
Table 78. Regeneron Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 79. Regeneron Recent Developments
Table 80. GlaxoSmithKline plc Company Details
Table 81. GlaxoSmithKline plc Business Overview
Table 82. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product
Table 83. GlaxoSmithKline plc Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 84. GlaxoSmithKline plc Recent Developments
Table 85. F. Hoffmann-La Roche Ltd. Company Details
Table 86. F. Hoffmann-La Roche Ltd. Business Overview
Table 87. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product
Table 88. F. Hoffmann-La Roche Ltd. Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 89. F. Hoffmann-La Roche Ltd. Recent Developments
Table 90. Novartis AG Company Details
Table 91. Novartis AG Business Overview
Table 92. Novartis AG Giant Cell Arteritis Therapeutic Product
Table 93. Novartis AG Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 94. Novartis AG Recent Developments
Table 95. AbbVie, Inc. Company Details
Table 96. AbbVie, Inc. Business Overview
Table 97. AbbVie, Inc. Giant Cell Arteritis Therapeutic Product
Table 98. AbbVie, Inc. Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 99. AbbVie, Inc. Recent Developments
Table 100. Bristol-Myers Squibb Company Company Details
Table 101. Bristol-Myers Squibb Company Business Overview
Table 102. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product
Table 103. Bristol-Myers Squibb Company Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 104. Bristol-Myers Squibb Company Recent Developments
Table 105. Abbott Company Details
Table 106. Abbott Business Overview
Table 107. Abbott Giant Cell Arteritis Therapeutic Product
Table 108. Abbott Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 109. Abbott Recent Developments
Table 110. Johnson & Johnson Services, Inc. Company Details
Table 111. Johnson & Johnson Services, Inc. Business Overview
Table 112. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product
Table 113. Johnson & Johnson Services, Inc. Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 114. Johnson & Johnson Services, Inc. Recent Developments
Table 115. Johns Hopkins Hospital Company Details
Table 116. Johns Hopkins Hospital Business Overview
Table 117. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product
Table 118. Johns Hopkins Hospital Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 119. Johns Hopkins Hospital Recent Developments
Table 120. Fortis Healthcare Company Details
Table 121. Fortis Healthcare Business Overview
Table 122. Fortis Healthcare Giant Cell Arteritis Therapeutic Product
Table 123. Fortis Healthcare Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 124. Fortis Healthcare Recent Developments
Table 125. American College of Rheumatology Company Details
Table 126. American College of Rheumatology Business Overview
Table 127. American College of Rheumatology Giant Cell Arteritis Therapeutic Product
Table 128. American College of Rheumatology Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 129. American College of Rheumatology Recent Developments
Table 130. Duke University Health System Company Details
Table 131. Duke University Health System Business Overview
Table 132. Duke University Health System Giant Cell Arteritis Therapeutic Product
Table 133. Duke University Health System Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 134. Duke University Health System Recent Developments
Table 135. Lahey Clinic Foundation Company Details
Table 136. Lahey Clinic Foundation Business Overview
Table 137. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product
Table 138. Lahey Clinic Foundation Revenue in Giant Cell Arteritis Therapeutic Business (2018-2024) & (US$ Million)
Table 139. Lahey Clinic Foundation Recent Developments
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Giant Cell Arteritis Therapeutic Market Share by Type: 2022 VS 2029
Figure 3. Prednisone Features
Figure 4. Methotrexate Features
Figure 5. Tocilizumab Features
Figure 6. Aspirin Features
Figure 7. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Giant Cell Arteritis Therapeutic Market Share by Application: 2022 VS 2029
Figure 9. Corticosteroids Case Studies
Figure 10. Immunosuppressive Agents Case Studies
Figure 11. Anticoagulants Case Studies
Figure 12. Others Case Studies
Figure 13. Giant Cell Arteritis Therapeutic Report Years Considered
Figure 14. Global Giant Cell Arteritis Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Giant Cell Arteritis Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Giant Cell Arteritis Therapeutic Market Share by Region: 2022 VS 2029
Figure 17. Global Giant Cell Arteritis Therapeutic Market Share by Players in 2022
Figure 18. Global Top Giant Cell Arteritis Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Therapeutic as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Giant Cell Arteritis Therapeutic Revenue in 2022
Figure 20. North America Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Giant Cell Arteritis Therapeutic Market Share by Type (2018-2029)
Figure 22. North America Giant Cell Arteritis Therapeutic Market Share by Application (2018-2029)
Figure 23. North America Giant Cell Arteritis Therapeutic Market Share by Country (2018-2029)
Figure 24. United States Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Giant Cell Arteritis Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Giant Cell Arteritis Therapeutic Market Share by Type (2018-2029)
Figure 28. Europe Giant Cell Arteritis Therapeutic Market Share by Application (2018-2029)
Figure 29. Europe Giant Cell Arteritis Therapeutic Market Share by Country (2018-2029)
Figure 30. Germany Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Giant Cell Arteritis Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Giant Cell Arteritis Therapeutic Market Share by Type (2018-2029)
Figure 38. China Giant Cell Arteritis Therapeutic Market Share by Application (2018-2029)
Figure 39. Asia Giant Cell Arteritis Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Giant Cell Arteritis Therapeutic Market Share by Type (2018-2029)
Figure 41. Asia Giant Cell Arteritis Therapeutic Market Share by Application (2018-2029)
Figure 42. Asia Giant Cell Arteritis Therapeutic Market Share by Region (2018-2029)
Figure 43. Japan Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Share by Country (2018-2029)
Figure 53. Brazil Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Giant Cell Arteritis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Sanofi Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 60. Kiniksa Pharmaceuticals, Ltd. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 61. Regeneron Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 62. GlaxoSmithKline plc Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 63. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 64. Novartis AG Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 65. AbbVie, Inc. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 66. Bristol-Myers Squibb Company Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 67. Abbott Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 68. Johnson & Johnson Services, Inc. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 69. Johns Hopkins Hospital Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 70. Fortis Healthcare Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 71. American College of Rheumatology Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 72. Duke University Health System Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 73. Lahey Clinic Foundation Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2018-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed